Bladder cancer risk factors

Jump to: navigation, search

Bladder cancer Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Bladder cancer from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Electrocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Biopsy

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Bladder cancer risk factors On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Bladder cancer risk factors

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Bladder cancer risk factors

CDC on Bladder cancer risk factors

Bladder cancer risk factors in the news

Blogs on Bladder cancer risk factors

Directions to Hospitals Treating Bladder cancer

Risk calculators and risk factors for Bladder cancer risk factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Steven C. Campbell, M.D., Ph.D.; Associate Editor(s)-in-Chief: Farima Kahe M.D. [2] Shanshan Cen, M.D. [3]

Overview

Common risk factors in the development of bladder cancer are smoking, occupational exposure to chemicals, chronic bladder irritation, chemotherapy, radiation therapy, arsenic, personal history of cancer in the urinary tract, congenital bladder anomalies, and aristolochic acids.

Common Risk Factors

Less Common Risk Factors

  • Less common risk factors in the development of bladder cancer include:[7][8][9][10]

References

  1. Janković S, Radosavljević V (2007). "Risk factors for bladder cancer". Tumori. 93 (1): 4–12. PMID 17455864.
  2. Letašiová S, Medve'ová A, Šovčíková A, Dušinská M, Volkovová K, Mosoiu C, Bartonová A (June 2012). "Bladder cancer, a review of the environmental risk factors". Environ Health. 11 Suppl 1: S11. doi:10.1186/1476-069X-11-S1-S11. PMC 3388449. PMID 22759493.
  3. Ugnat AM, Luo W, Semenciw R, Mao Y (2004). "Occupational exposure to chemical and petrochemical industries and bladder cancer risk in four western Canadian provinces". Chronic Dis Can. 25 (2): 7–15. PMID 15554606.
  4. Bhatt VR, Loberiza FR, Tandra P, Krishnamurthy J, Shrestha R, Wang J (January 2014). "Risk factors, therapy and survival outcomes of small cell and large cell neuroendocrine carcinoma of urinary bladder". Rare Tumors. 6 (1): 5043. doi:10.4081/rt.2014.5043. PMC 3977167. PMID 24711904.
  5. Vermeulen SH, Hanum N, Grotenhuis AJ, Castaño-Vinyals G, van der Heijden AG, Aben KK, Mysorekar IU, Kiemeney LA (February 2015). "Recurrent urinary tract infection and risk of bladder cancer in the Nijmegen bladder cancer study". Br. J. Cancer. 112 (3): 594–600. doi:10.1038/bjc.2014.601. PMC 4453642. PMID 25429525.
  6. Hess MJ, Zhan EH, Foo DK, Yalla SV (2003). "Bladder cancer in patients with spinal cord injury". J Spinal Cord Med. 26 (4): 335–8. PMID 14992333.
  7. Gu J, Wu X (May 2011). "Genetic susceptibility to bladder cancer risk and outcome". Per Med. 8 (3): 365–374. doi:10.2217/PME.11.15. PMC 3172962. PMID 21927616.
  8. Zhang X, Zhang Y (September 2015). "Bladder Cancer and Genetic Mutations". Cell Biochem. Biophys. 73 (1): 65–9. doi:10.1007/s12013-015-0574-z. PMID 27352265.
  9. Castaño-Vinyals G, Cantor KP, Malats N, Tardon A, Garcia-Closas R, Serra C, Carrato A, Rothman N, Vermeulen R, Silverman D, Dosemeci M, Kogevinas M (January 2008). "Air pollution and risk of urinary bladder cancer in a case-control study in Spain". Occup Environ Med. 65 (1): 56–60. doi:10.1136/oem.2007.034348. PMID 17634245.
  10. Fortuny J, Kogevinas M, Zens MS, Schned A, Andrew AS, Heaney J, Kelsey KT, Karagas MR (August 2007). "Analgesic and anti-inflammatory drug use and risk of bladder cancer: a population based case control study". BMC Urol. 7: 13. doi:10.1186/1471-2490-7-13. PMC 2018698. PMID 17692123.

Linked-in.jpg